Forxiga Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing Brand Resources

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

5 mg: Yellow, biconvex, 0.7 cm diameter round, film-coated tablets with "5" engraved on one side and "1427" engraved on the other side.
10 mg: Yellow, biconvex, approximately 1.1. x 0.8 cm diagonally diamond-shaped, film-coated tablets with "10" engraved on one side and "1428" engraved on the other side.
Each tablet contains dapagliflozin propanediol monohydrate equivalent to 5 mg or 10 mg of dapagliflozin.
Excipient with known effect: Each tablet contains 25 mg or 50 mg of lactose.
Excipients/Inactive Ingredients: Tablet core: Microcrystalline cellulose (E460i), Anhydrous lactose, Crospovidone (E1202), Silicon dioxide (E551), Magnesium stearate (E470b).
Film-coating: Polyvinyl alcohol (E1203), Titanium dioxide (E171), Macrogol 3350, Talc (E553b), Iron oxide yellow (E172).

Manufacturer:

AstraZeneca

Distributor:

Zuellig Pharma